Update shared on 29 Nov 2025
Fair value Increased 2.32%Analysts have increased their price target for Medco Energi Internasional from Rp1,797.23 to Rp1,838.98, citing improved revenue growth expectations and a slightly more favorable discount rate.
What's in the News
- The Board of Directors of PT Medco Energi Internasional Tbk has authorized a buyback plan on September 4, 2025 (Key Developments).
- PT Medco Energi Internasional Tbk (IDX:MEDC) announces a share repurchase program with plans to buy back up to $50 million worth of common stock in an effort to deliver greater value to shareholders (Key Developments).
Valuation Changes
- Consensus Analyst Price Target has risen slightly from IDR 1,797.23 to IDR 1,838.98.
- Discount Rate has fallen marginally, decreasing from 15.54% to 15.46%.
- Revenue Growth expectations have increased substantially from 1.03% to 1.69%.
- Net Profit Margin is projected to decline modestly from 17.40% to 17.22%.
- Future P/E ratio has edged up, moving from 9.37x to 9.49x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.